156 related articles for article (PubMed ID: 25052597)
21. Mobilization of peripheral blood progenitor cells by high-dose Ara C, VP-16 and recombinant human granulocyte colony-stimulating factor: factors affecting progenitor cell yields.
Shimazaki C; Yamagata N; Tatsumi T; Hirata T; Oku N; Ashihara E; Goto H; Inaba T; Fujita N; Haruyama H
Bone Marrow Transplant; 1995 May; 15(5):763-7. PubMed ID: 7545490
[TBL] [Abstract][Full Text] [Related]
22. Good and poor CD34+ cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells.
Pastore D; Specchia G; Mestice A; Liso A; Pannunzio A; Carluccio P; Buquicchio C; Greco G; Ciuffreda L; Pietrantuono G; Liso V
Bone Marrow Transplant; 2004 Jun; 33(11):1083-7. PubMed ID: 15077126
[TBL] [Abstract][Full Text] [Related]
23. ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF.
Lee JL; Kim S; Kim SW; Kim EK; Kim SB; Kang YK; Lee J; Kim MW; Park CJ; Chi HS; Huh J; Kim SH; Suh C
Bone Marrow Transplant; 2005 Mar; 35(5):449-54. PubMed ID: 15654353
[TBL] [Abstract][Full Text] [Related]
24. [Mobilization of autologous peripheral blood stem cells with etoposide and recombinant human granulocyte colony stimulating factor in malignant tumor patients].
Shi YK; He XH; Han XH; Yang JL; Liu P; Zhang CG; Ai B
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):360-3. PubMed ID: 15312348
[TBL] [Abstract][Full Text] [Related]
25. Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens.
Stewart DA; Guo D; Morris D; Poon MC; Ruether BA; Jones AR; Klassen J; Auer I; Luider J; Chaudhry A; Brown C; Russell JA
Bone Marrow Transplant; 1999 Jan; 23(2):111-7. PubMed ID: 10197794
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy of IA regimen followed by FLAG regimen in the treatment of acute myeloid leukaemia].
Qian SX; Li JY; Hong M; Lu H; Wu HX; Qiu HX; Zhang SJ; Chen LJ; Xu W; Sheng RL
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):22-5. PubMed ID: 19563030
[TBL] [Abstract][Full Text] [Related]
27. A randomized comparison of modified intermediate-dose Ara-C versus high-dose ara-c in post-remission therapy for acute myeloid leukemia.
Fukushima T; Urasaki Y; Yamaguchi M; Ueda M; Morinaga K; Haba T; Sugiyama T; Nakao S; Origasa H; Umehara H; Ueda T
Anticancer Res; 2012 Feb; 32(2):643-7. PubMed ID: 22287757
[TBL] [Abstract][Full Text] [Related]
28. Peripheral blood stem cell collection in children with acute leukemia: effectiveness of the 'DIAVE' mobilizing regimen.
Balduzzi A; Perseghin P; Dassi M; Bonanomi S; Rovelli A; Gaipa G; Biondi A; Uderzo C
Bone Marrow Transplant; 2002 Oct; 30(7):413-6. PubMed ID: 12368951
[TBL] [Abstract][Full Text] [Related]
29. Autologous stem cell transplantation for advanced acute myeloid leukemia.
Linker CA; Damon LE; Ries CA; Navarro WA; Case D; Wolf JL
Bone Marrow Transplant; 2002 Feb; 29(4):297-301. PubMed ID: 11896426
[TBL] [Abstract][Full Text] [Related]
30. High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease.
Weaver CH; Schwartzberg L; Li W; Hazelton B; West W
Bone Marrow Transplant; 1996 May; 17(5):715-21. PubMed ID: 8733687
[TBL] [Abstract][Full Text] [Related]
31. [Clinical study on single-dose rhG-CSF combined with chemotherapy in autologous peripheral blood stem cell transplantation].
Tian H; Zhou SY
Ai Zheng; 2002 Aug; 21(8):896-9. PubMed ID: 12478902
[TBL] [Abstract][Full Text] [Related]
32. Remobilization of hematopoietic stem cells with high-dose methotrexate and cytarabine in patients with non-Hodgkin's lymphoma and multiple myeloma after failure to mobilize with chemotherapy and cytokines.
Park SJ; Yoon DH; Kim S; Lee K; Park JS; Jang S; Park CJ; Chi HS; Park CS; Huh J; Suh C
Transfusion; 2014 Mar; 54(3):509-15. PubMed ID: 23800093
[TBL] [Abstract][Full Text] [Related]
33. Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline.
Fukushima T; Kawabata H; Sawaki T; Satoh T; Nakamura T; Iwao H; Nakajima A; Sakai T; Miki M; Fujita Y; Tanaka M; Kawanami T; Masaki Y; Okazaki T; Umehara H
Anticancer Res; 2012 Apr; 32(4):1347-53. PubMed ID: 22493369
[TBL] [Abstract][Full Text] [Related]
34. [Successful collection of peripheral blood stem cells mobilized by a combination of G-CSF with high-dose Ara-C or high-dose etoposide].
Kuzuyama Y; Sonoda Y; Sakabe H; Nakagawa H; Fujii H; Abe T
Rinsho Ketsueki; 1993 Dec; 34(12):1525-31. PubMed ID: 7507531
[TBL] [Abstract][Full Text] [Related]
35. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
[TBL] [Abstract][Full Text] [Related]
36. Intermediate-dose cytarabine plus G-CSF as mobilization regimen for newly diagnosed multiple myeloma and heavily pre-treated patients with hematological and non-hematological malignancies.
Callera AF; Rosa ES; Callera F
Transfus Apher Sci; 2019 Jun; 58(3):318-322. PubMed ID: 30961974
[TBL] [Abstract][Full Text] [Related]
37. Age has no influence on mobilization of peripheral blood stem cells in acute myeloid leukemia.
Ferrara F; Viola A; Copia C; Falco C; D'Elia R; Tambaro FP; Correale P; D'Amico MR; Vicari L; Palmieri S
Hematol Oncol; 2007 Jun; 25(2):84-9. PubMed ID: 17361983
[TBL] [Abstract][Full Text] [Related]
38. Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF.
Ricca I; Compagno M; Ladetto M; Rocci A; Dell'Aquila M; Omedè P; De Marco F; D'Antico S; Caracciolo D; Ferrero D; Carlo-Stella C; Tarella C
Leukemia; 2005 Apr; 19(4):644-51. PubMed ID: 15716989
[TBL] [Abstract][Full Text] [Related]
39. Mobilization of peripheral blood stem cells for autologous transplantation patients with hematological malignancies: Influence of disease, mobilization method, age and sex.
Zhang C; Chen X; Zhang X; Gao L; Kong P; Wang Q; Peng X; Liu H
Transfus Apher Sci; 2008 Aug; 39(1):21-8. PubMed ID: 18599353
[TBL] [Abstract][Full Text] [Related]
40. Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers.
Giebel S; Kruzel T; Czerw T; Sadus-Wojciechowska M; Najda J; Chmielowska E; Grosicki S; Jurczyszyn A; Pasiarski M; Nowara E; Glowala-Kosinka M; Chwieduk A; Mitrus I; Smagur A; Holowiecki J
Bone Marrow Transplant; 2013 Jul; 48(7):915-21. PubMed ID: 23292239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
